Digital medical services platform Teladoc Health (NYSE: TDOC) reported Q3 2026 results beating Wall Street’s revenue expectations, but sales fell by 3.4% year on year to $605.1 million. On the other hand, next quarter’s revenue guidance of $592 million was less impressive, coming in 0.8% below analysts’ estimates. Its GAAP loss of $0.15 per share was 30.8% above analysts’ consensus estimates.

Is now the time to buy TDOC? Find out in our full research report (it’s free for active Edge members).

StockStory’s take

Teladoc’s third-quarter results were met with a significant positive market reaction, reflecting investor confidence in the company’s execution despite a year-over-year revenue decline. Management cited robust progress in its core strategic initiatives, particularly the rapid expansion of insurance-covered mental health sessions through BetterHelp and operational improvements within integrated care. CEO Charles Divita highlighted that “consolidated revenue came in near the upper end of our guidance range and adjusted EBITDA above guidance, with both segments contributing to the quarter’s performance.” The company also welcomed new CFO Mike Grasher, signaling a continued focus on financial discipline and operational efficiency.

Looking ahead, Teladoc’s guidance is shaped by ongoing shifts in the virtual care market, especially the transition of BetterHelp toward an insurance-based business model and the anticipated broader launch of Teladoc 1. Divita emphasized that while cash pay performance was better than anticipated, “we expect ongoing pressure in the cash pay market including as we further evolve BetterHelp’s approach to advertising and marketing.” The company is prioritizing growth in insurance revenue and expanding provider capacity, while also investing in new hybrid care models that integrate physical and virtual services—initiatives management believes will drive differentiation through 2027 and beyond.

Key insights from management’s remarks

Management attributed Q3 performance to the acceleration of insurance revenue at BetterHelp, operational efficiencies in integrated care, and the initial rollout of new care models, while also addressing ongoing challenges in the cash pay market and the competitive landscape.

• BetterHelp insurance transition: Management made significant progress in shifting BetterHelp’s U.S. business toward insurance reimbursement, with insurance-covered sessions reaching an annualized revenue run rate over $140 million and 36% of new U.S. users coming from insurance, up 8 percentage points sequentially.
• Provider network expansion: The company credentialed over 3,000 new therapists for BetterHelp during Q3, bringing the total to more than 11,000. This expansion is designed to handle growing insurance demand and improve patient access, with ongoing initiatives targeting local market capacity and evolving therapist compensation programs.
• Integrated care operational improvements: Integrated care achieved higher margins due to productivity initiatives and disciplined cost management, even as the business faced a mix shift toward visit-based arrangements and continued to grow international operations.
• Teladoc 1 launch and adoption: The initial rollout of Teladoc 1, a comprehensive care model leveraging adaptive AI and multidisciplinary teams, began with launch partners in Q3. Management expects commercial momentum to build as the product moves toward broader market availability in 2027.
• Hybrid care and technology innovation: Teladoc completed an acquisition to expand hybrid care services (combining virtual and in-person healthcare), and rolled out new AI-powered features in its Solo platform, such as contact-free vital sign measurement, aiming to reduce administrative burden and enhance provider efficiency.

Drivers of future performance

Teladoc’s outlook is shaped by the continued pivot to insurance-based mental health services, the scaling of integrated and hybrid care models, and cautious expectations for cash pay.

• Insurance-driven BetterHelp growth: Management believes scaling insurance access and increasing therapist capacity will drive sequential quarterly growth in insurance revenue through 2027. The company’s contracts now cover over 150 million insured lives, providing a large addressable market for expansion.
• Cash pay headwinds and advertising pullback: Ongoing pressure in the cash pay segment is expected as Teladoc reduces advertising and marketing spend, particularly during less efficient periods such as the holidays. This shift is anticipated to lower cash pay user acquisition, in line with management’s revised strategy to create a more durable insurance-based business.
• Investment in product innovation and hybrid models: Teladoc plans to invest in the broader rollout of Teladoc 1 and hybrid care services, which target both hospital systems and direct-to-patient engagement. Management expects these initiatives to differentiate the company’s value proposition and support margin expansion, but notes that execution risks and evolving customer needs remain key variables.

Catalysts in upcoming quarters

In the coming quarters, the StockStory team will focus on (1) tracking the ramp of insurance-covered sessions and therapist network expansion at BetterHelp, (2) monitoring adoption and client feedback on Teladoc 1 as the company targets broader rollout, and (3) assessing the scaling of hybrid care offerings in both the U.S. and international markets. Additionally, shifts in advertising strategy and integration of AI-powered tools will be important markers for operational progress.

Teladoc currently trades at $7.55, up from $6.85 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free).

Stocks that trumped tariffs

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.